The Automation Partnership (TAP), a world leading manufacturer of innovative industrial automation for life science applications, is delighted to announce the Remedi consortium has chosen a CompacT SelecT automated cell culture system for use in the first major European study on automating the manufacture of regenerative medicine products.
